Ci Investments Inc. Adaptive Biotechnologies Corp Transaction History

Ci Investments Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$25.17 - $36.85 $176 - $257	-7 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$30.02 - $39.87 $210 - $279	7 New	7 $0
Q3 2020 Nov 09, 2020	SELL	$35.79 - $48.81 $2.14 Million - $2.92 Million	-59,902 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$30.31 - $53.51 $1.48 Million - $2.62 Million	48,902 Added 444.56%	59,902 $1.85 Million
Q2 2019 Aug 12, 2019	BUY	$40.3 - $48.3 $443,299 - $531,300	11,000 New	11,000 $531,000

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Ci Investments Inc., based on Form 13F filings with the SEC.

Stay updated on Ci Investments Inc. with notifications on news.